US 7312340
Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one
granted A61PA61P1/02A61P31/04
Quick answer
US patent 7312340 (Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/02, A61P31/04